Increasing evidences have demonstrated HMGB1 act as a critical molecular target in multiple human diseases including infectious diseases, acute lung injury, brain injury, liver disease, intestinal barrier disruption, vascular barrier disruption, precancerous lesions21–23. This evidence concerns the gene HMGB1 and infectious disease.